Product Reports Resources Pricing Login Book a demo

Echosens

Biotech & Life Sciences · Paris, France · Founded 2001

Echosens is a French company that specializes in non-invasive medical devices for the diagnosis and monitoring of chronic liver diseases. The company's flagship product, the FibroScan, is a non-invasive device that uses patented Vibration-Controlled Transient Elastography (VCTE) to measure liver stiffness and ultrasound attenuation for steatosis quantification. This technology provides a quantitative assessment of liver fibrosis and steatosis, which are key markers of liver health. The company's business model is based on the sale of its FibroScan devices and related consumables to hospitals, clinics, and research institutions worldwide. Echosens also offers a range of services, including training, technical support, and clinical research support, to its customers. The company's target market includes hepatologists, gastroenterologists, and other healthcare professionals involved in the diagnosis and management of liver diseases. Echosens has a global presence, with offices in Europe, North America, and Asia. The company's products are sold in over 100 countries, and it has a strong network of distributors and partners. Echosens is a well-established player in the liver disease diagnostics market, and its products are widely recognized for their accuracy, reliability, and ease of use. Keywords: medical devices, liver disease, diagnostics, non-invasive, FibroScan, VCTE, hepatology, gastroenterology, healthcare, medical technology

Valuation $100–500M
Revenue $50–100M
Headcount 100–500
Total funding $10–50M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Echosens and the history behind them.

Investors

6 investors on Echosens's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 3 investors entered at this stage
Cathay Capital
Agoranov
EIT Health
Series B+ 3 investors entered at this stage
PSL University
ESPCI Paris - PSL University
French National Centre for Scientific Research - CNRS

Global footprint

Where Echosens has talent and traffic

Workforce by country
22 countries with
team presence
🇫🇷 France50.3%
🇺🇸 United States28%
🇬🇧 United Kingdom4.7%
🇩🇪 Germany3%
🇮🇳 India2.4%
Top 5 of 22 shown
Web traffic by country
34K monthly visits
across markets
🇺🇸 United States35.3%
🇮🇳 India32.1%
🇮🇹 Italy8.2%
🇫🇷 France4.7%
🇬🇧 United Kingdom4.4%
Top 5 markets shown

Talent graph

The shape of Echosens's talent

Dealroom maps Echosens's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

7 standout operatorsDealroom-flagged across the org
3 AI specialistsincl. 1 core researchers
384 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Echosens's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Echosens

An AI-synthesized read of the highest-engagement posts about Echosens on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Echosens on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.